Clinical Trials Sponsored by Protox Therapeutics
Total 7302 results
-
Karuna TherapeuticsActive, not recruiting
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
Elevar TherapeuticsCompletedAdenoid Cystic CarcinomaUnited States, Korea, Republic of
-
Sage TherapeuticsCompletedParkinson Disease | Cognitive DysfunctionUnited States
-
Intrommune TherapeuticsCompletedPeanut AllergyUnited States
-
Lyra TherapeuticsCompletedChronic Sinusitis | Chronic Rhinosinusitis (Diagnosis)Poland, Australia, New Zealand, Austria, Czechia
-
Freeline TherapeuticsTerminatedHemophilia BUnited States, United Kingdom
-
Spark TherapeuticsCompletedHematologic Diseases | Hemophilia A | Blood Coagulation Disorders, Inherited | Coagulation Protein Disorders | Hemorrhagic Disorders | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Blood Coagulation Disorder | Factor VIII DeficiencyUnited States, Australia, Thailand, Canada
-
Tempest TherapeuticsCompletedSarcoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Pancreatic Cancer | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Non-small Cell Lung Cancer | Urothelial Carcinoma | GastroEsophageal Cancer | Triple-Negative Breast Cancer | Metastatic Castration Resistant Prostate...United States
-
PTC TherapeuticsTerminatedCOVID-19 | Pneumonia | CoronavirusSpain, United States, Australia, France, Brazil, Mexico, South Africa, Belgium, Colombia, Poland, Portugal
-
Encoded TherapeuticsTerminatedDravet SyndromeUnited States, Spain, Australia, United Kingdom
-
Freeline TherapeuticsTerminatedLysosomal Storage Diseases | Fabry DiseaseUnited States, Norway, Germany, Austria, United Kingdom, Italy, Canada
-
Monopar TherapeuticsTerminatedChemoradiotherapy-Induced Severe Oral MucositisUnited States, Spain, Germany, France, Puerto Rico
-
Celldex TherapeuticsCompletedCold Urticaria | Symptomatic Dermographism | Cholinergic Urticaria | Cold Contact Urticaria | Symptomatic DermatographismGermany
-
Harpoon TherapeuticsCompletedAdvanced Cancers Associated With Mesothelin ExpressionUnited States
-
Corcept TherapeuticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States, United Kingdom
-
Amicus TherapeuticsCompletedFabry DiseaseJapan, Taiwan, Turkey, United States, Brazil
-
Frequency TherapeuticsTerminatedHearing Loss, SensorineuralUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
Serina TherapeuticsActive, not recruiting
-
Effector TherapeuticsCompleted
-
Corcept TherapeuticsCompletedNon-alcoholic Steatohepatitis (NASH) | Antipsychotic Induced Weight GainUnited States
-
Mahana TherapeuticsCompleted
-
101 TherapeuticsTerminated
-
Corcept TherapeuticsCompletedNeoplasms | Cushing SyndromeUnited States
-
OX2 TherapeuticsActive, not recruiting
-
ProQR TherapeuticsTerminatedEye Diseases | Retinitis Pigmentosa | Eye Diseases, Hereditary | Vision Disorders | Retinal Disease | Eye Disorders Congenital | Usher Syndrome Type 2 | Deaf BlindUnited States, United Kingdom
-
Stemirna TherapeuticsActive, not recruitingEfficacy | Safety | ImmunogenicityLao People's Democratic Republic
-
ProQR TherapeuticsTerminatedRetinitis Pigmentosa | Usher Syndrome Type 2United States, Canada, France
-
ProQR TherapeuticsCompletedLeber's Congenital AmaurosisUnited States, Belgium
-
101 TherapeuticsActive, not recruitingVirus Diseases | COVID-19 | Infectious Disease | Glucocorticoids ToxicityIndia
-
Rubius TherapeuticsTerminated
-
Highlight TherapeuticsTerminatedGastric Cancer | Colorectal Cancer | Oesophageal CancerSpain, Belgium, Italy
-
Rubius TherapeuticsTerminatedNon Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Cutaneous Melanoma | TNBC - Triple-Negative Breast CancerUnited States
-
Pendulum TherapeuticsCompletedDiabetes Mellitus | Diabetes Type 2United States
-
Rubius TherapeuticsTerminated
-
Corcept TherapeuticsCompleted
-
Prelude TherapeuticsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Non Hodgkin LymphomaUnited States
-
RANI TherapeuticsCompleted
-
Sangamo TherapeuticsTerminatedMucopolysaccharidosis II | MPS IIUnited States
-
Cingulate TherapeuticsCompletedHealthy Volunteers in Fed and Fasted StateUnited States
-
Adiso TherapeuticsCompletedClostridium Difficile Infection RecurrenceUnited States, Canada
-
ONL TherapeuticsCompletedRhegmatogenous Retinal Detachment - Macula OffAustralia
-
Akebia TherapeuticsCompletedAnemia | Dialysis-dependent Chronic Kidney DiseaseUnited States
-
United TherapeuticsCompletedPulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and EmphysemaUnited States, Puerto Rico
-
Amnis TherapeuticsTerminatedIschemic StrokeSpain, Sweden
-
Elevar TherapeuticsCompletedGastric Cancer | Gastric AdenocarcinomaUnited States, United Kingdom, Korea, Republic of, France, Taiwan, Japan, Russian Federation, Germany, Italy, Poland, Romania, Ukraine
-
Sage TherapeuticsCompleted